Interview with Narayana Rao, Vice President, Biopharma, AMEA in BioSpectrum Asia Edition (April 2021) on COVID-19 vaccine needs
In the April 2021 issue of BioSpectrum, Asia Edition, Narayana Rao, Vice President, Biopharma, AMEA shared his views on the challenges facing the global vaccine industry at the time. He highlighted Avantor’s support of companies combating the COVID-19 pandemic in each arena - from testing patients to vaccine development and manufacturing to managing supply chain challenges.
Rao also offered insight into the predicted COVID-19 vaccine needs and the ways in which the AMEA region would step up to meet those needs. In addition, he discussed the biopharmaceutical market’s opportunities moving forward.
Narayana Rao Rapolu
Vice President – Biopharma, Asia Pacific Middle East Africa & General Manager – South East Asia Taiwan (Including ANZ)
Responsible for developing and delivering Avantor’s global solutions to customers in AMEA region. Prior to joining Avantor Mr. Rapolu held a variety of Sales, business development, general management, integrated solutions, strategic partnerships positions with Pall/Danaher & Life Technologies. Mr Rapolu earned Masters in Biotechnology from Bangalore University in India and Executive General Management Programme from Indian Institute of Management Bangalore.